The four differences that matter
Licensing: a 503A pharmacy is licensed by state boards of pharmacy; a 503B outsourcing facility registers with the FDA and is inspected on a federal schedule.
Prescriptions: a 503A preparation requires a patient-specific prescription. A 503B facility may compound without one, for office stock.
Standards: 503B facilities must follow current good manufacturing practice. 503A pharmacies follow pharmacy compounding standards, which are real but different.
Scale: 503A is one patient at a time. 503B is batch production.
Why a telehealth protocol comes from a 503A pharmacy
Because it is prescribed for you specifically, after a physician reads your labs. That is the 503A pathway by definition. A service shipping you a personalised preparation should be able to name the pharmacy, and the pharmacy should be licensed in your state.
Where this goes wrong
The failure mode is a seller that uses the vocabulary of compounding — "pharmacy grade", "compounded in the USA" — while operating as neither a 503A nor a 503B: no prescription, no licensed prescriber, no state licence covering you. The words are borrowed. The accountability is not.
Key points
- 503A: state-licensed, patient-specific, one at a time.
- 503B: FDA-registered, batch, for clinical stock.
- Borrowed vocabulary is the tell. Ask which one, and for the licence.
AZZA Medical is not a medical provider and does not practice medicine. Medical services are provided exclusively by independently licensed physicians of our partner physician network and their affiliated professional entities.
Compounded drugs are not FDA-approved and have not been evaluated by FDA for safety or effectiveness.
This is not emergency care. AZZA Medical does not provide urgent or emergency medical services. If you are experiencing a medical emergency, call 911 or go to your nearest emergency room.